Breast cancer patients have increased risk of developing mTOR inhibitor ‐associated stomatitis

This study emphasizes the high prevalence of mIAS in patients using everolimus, in particular, in patients with breast cancer.

Source: Oral Diseases - February 26, 2018 Category: ENT & OMF Authors: MHA Lima, GNM Hajj, VCC Lima, FA Alves Tags: PROF SCULLY MEMORIAL ISSUE Source Type: research